Showing results (1-10 of 1,462) with videos related to
Sort By:
Pageof 147
Recombinant DNA Technical Bulletin|March 1, 1986
Genetically-engineered microorganisms: I. Identification, classification, and strain historyH Strauss, D Hattis, G Page, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|June 1, 1990
Pharmacokinetic principles for dose-rate extrapolation of carcinogenic risk from genetically active agentsD HattisEnvironmental Health Perspectives|January 1, 1991
Use of biological markers and pharmacokinetics in human health risk assessmentD HattisEnvironmental Health Perspectives|April 1, 1996
The challenge of mechanism-based modeling in risk assessment for neurobehavioral end pointsD HattisEnvironmental Health Perspectives|October 1, 1981
Needs for public health intervention and needs for new research on vinyl halides and their polymers: a public policy perspectiveD HattisToxicology|July 17, 1996
Human interindividual variability in susceptibility to toxic effects: from annoying detail to a central determinant of riskD HattisEnvironmental Toxicology and Pharmacology|July 26, 2011
Variability in susceptibility - how big, how often, for what responses to what agents?D HattisEnvironmental Toxicology and Pharmacology|July 26, 2011
Human variability in susceptibility How big, how often, for what responses to what agents?D HattisEnvironmental Geochemistry and Health|November 8, 2013
The use of well-defined biomarkers (such as blood lead) in risk assessmentD HattisRisk Analysis : an Official Publication of the Society for Risk Analysis|August 1, 1994
Human interindividual variability--a major source of uncertainty in assessing risks for noncancer health effectsD Hattis, K SilverPageof 147